This Week
  • Architect David Hanlon has worked with some of the area's leading developers.

  • For startup companies, legal and accounting missteps can prove costly.

  • Wilmorite hopes soon to win approval for $425M casino in Seneca County.

  • ID Signsystems Inc. has grown from a local company into an international business.

  • Robert Linton guides Jazz 90.1 through a new era in media.

  • The RBJ 75 supplement presents a list of the 75 largest private-sector employers.

VirtualScopics and partner firm form advisory board

Rochester Business Journal
July 16, 2014

VirtualScopics Inc. has formed a scientific advisory board with Ixico plc, officials announced.

"The formation of this joint scientific advisory board is an important initiative of the international commercial and operational alliance we signed with Ixico plc on June 27, 2014," said Eric Converse, interim president and CEO of VirtualScopics in a statement. "We are very honored and pleased that our initial members have agreed to pioneer this very strategic effort on both companies' parts."

Edward Ashton, VirtualScopics’ chief scientific officer, will chair the board, which has seven members.

"Our board members are all distinguished opinion leaders from a broad range of disciplines related to the conduct of imaging in clinical trials,” Ashton said in a statement. “The board will meet quarterly and focus on early and late phase oncology, cardiology, metabolic disorders and neurology."

In addition to Ashton, the founding members of the scientific advisory board are:

  • Derek Hill, CEO, Ixico
  • Jonathan Riek, chief technical officer, VirtualScopics
  • Jeffrey Evelhoch, vice president and global head of imaging in early stage development; Merck Research Laboratories
  • Dirk Reitsma M.D., vice president of global product development and therapeutic area head of oncology, Pharmaceutical Product Development LLC
  • Claude Sirlin M.D., professor of radiology and chief of body imaging, department of radiology; University of California, San Diego
  • Karl Schwarz  M.D.; University of Rochester

"A benefit of the alliance between Ixico and VirtualScopics is the ability and opportunity for us to think more strategically about the evolving needs of our customers in the pharmaceutical industry and the ways they can best use imaging in their clinical studies," said Derek Hill, CEO of Ixico, in a statement. “The scientific advisory board provides a forum for key alliance scientists to work with external experts to map current and future roles for imaging in a number of disease categories."

(c) 2014 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or e-mail service@rbj.net.


What You're Saying 

There are no comments yet. Be the first to add yours!

Post Your Own Comment

 
Username:
Password:

Not registered? Sign up now!
 

To Do   Text Size
Post CommentPost A Comment eMail Size1
View CommentsView All Comments PrintPrint Size2
ReprintsReprints Size3
  • E-mailed
  • Commented
  • Viewed
RBJ   Google